Small Cap Stocks Down Under 4 November 2022: Healthia (ASX:HLA)

Healthia: An allied healthcare roll-up

The health industry on the ASX is saturated with healthcare companies trying to develop the next big drug or medical device. But today, we’re looking at Healthia (ASX:HLA) a company with a solid existing business. It is a rollup of allied healthcare businesses across several spaces, particularly podiatry and physiotherapy. The company is profitable and has a track record of growth since listing, but shares have taken a hit in the last 12 months as investors become wary of M&A-heavy companies.

Click here to read the previous edition of Small Cap Stocks Down Under published 28 October 2022.

For in-depth research reports on ASX-listed stocks, check out our parent company, Pitt Street Research, or follow us on Facebook and Twitter.